Supplemental material
Journal of Enzyme Inhibition and Medicinal Chemistry
Volume 34, 2019 - Issue 1
Related Research Data
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies.
Source:
Springer Science and Business Media LLC
Novel inhibitor of p38 MAP kinase as an anti-TNF-alpha drug: discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatoid arthritis agent.
Source:
American Chemical Society (ACS)
Enhanced anti-rheumatic activity of methotrexate-entrapped ultradeformable liposomal gel in adjuvant-induced arthritis rat model.
Source:
Elsevier
The cyclooxygenase-2/thromboxane A2 pathway: a bridge from rheumatoid arthritis to lung cancer?
Source:
Elsevier BV
Discovery of novel PI3-kinase δ specific inhibitors for the treatment of rheumatoid arthritis: taming CYP3A4 time-dependent inhibition.
Source:
American Chemical Society (ACS)
Synthesis and activity of substituted 4-(indazol-3-yl)phenols as pathway-selective estrogen receptor ligands useful in the treatment of rheumatoid arthritis.
Source:
American Chemical Society (ACS)
Small Molecule Inhibitors of NF-κB and JAK/STAT Signal Transduction Pathways as Promising Anti-Inflammatory Therapeutics
Source:
Bentham Science Publishers Ltd.
Role of nitric oxide and reactive oxygen species in arthritis.
Source:
Bentham Science Publishers Ltd.
Novel resveratrol-based flavonol derivatives: Synthesis and anti-inflammatory activity in vitro and in vivo.
Source:
Elsevier BV
Resveratrol-based cinnamic ester hybrids: synthesis, characterization, and anti-inflammatory activity.
Source:
Taylor & Francis
Redox behavior and biological properties of ferrocene bearing porphyrins.
Source:
Elsevier BV
Linking provided by
